Changes of peripheral α-melanocyte-stimulating hormone in childhood obesity

Metabolism: Clinical and Experimental

Volumn 59, Issue 2, 2010, Pages 186-194

  Roth, Christian L ^a   Enriori, Pablo J ^b,c   Gebhardt, Ursel ^d   Hinney, Anke ^e   Müller, Hermann L ^d   Hebebrand, Johannes ^e   Reinehr, Thomas ^f   Cowley, Michael A ^b,c  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MONASH UNIVERSITY   (Australia)

^d KLINIKUM OLDENBURG   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; HYDROCORTISONE; INSULIN; MELANOCORTIN 4 RECEPTOR;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; CONTROLLED STUDY; CRANIOPHARYNGIOMA; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; TEST MEAL; WEIGHT CHANGE;

ADOLESCENT; ALPHA-MSH; BODY MASS INDEX; BODY WEIGHT; CHILD; CRANIOPHARYNGIOMA; FEMALE; GENOTYPE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MUTATION; OBESITY; PITUITARY NEOPLASMS; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 74049092632     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.06.031     Document Type: Article

References (36)

1. Cone R.D. Studies on the physiological functions of the melanocortin system. Endocr Rev 27 (2006) 736-749
2. Raffin-Sanson M.L., de Keyzer Y., and Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149 (2003) 79-90
3. Smith A.I., and Funder J.W. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9 (1988) 159-179
4. Ying J., Gu X., Cai M., Dedek M., Vagner J., Trivedi D.B., et al. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor. J Med Chem 49 (2006) 6888-6896
5. Coates P.J., Doniach I., Hale A.C., and Rees L.H. The distribution of immunoreactive alpha-melanocyte-stimulating hormone cells in the adult human pituitary gland. J Endocrinol 111 (1986) 335-342
6. Hinney A., Bettecken T., Tarnow P., Brumm H., Reichwald K., Lichtner P., et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab 91 (2006) 1761-1769
7. Müller H.L., Bueb K., Bartels U., Roth C., Harz K., Graf N., et al. Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life. Klin Pädiatr 213 (2001) 244-249
8. Müller H.L. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69 (2008) 193-202
9. Lustig R.H., Post S., Srivannaboon K., Rose S., Danish R., Burghen G., et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88 (2003) 611-616
10. Poretti A., Grotzer M., Ribi K., Schönle E., and Boltshauser E. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46 (2004) 220-229
11. Karavitaki N., Cudlip S., Adams C., and Wass J. Craniopharyngiomas. Endocr Rev 27 (2006) 371-397
12. Kendall-Taylor P., Jönsson P., Abs R., Erfurth E.M., Koltowska-Häggström M., Price D., et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152 (2005) 557-567
13. Schwartz M.W., Woods S.C., Porte Jr. D., Seeley R.J., and Baskin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
14. Rossi M., Kim M.S., Morgan D.G.A., Small C.J., Edwards C.M.B., Sunter D., et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139 (1998) 4428-4431
15. Boston B.A., and Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137 (1996) 2043-2050
16. An J.J., Rhee Y., Kim S.H., Kim D.M., Han D.H., Hwang J.H., et al. Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J Biol Chem 282 (2007) 2862-2870
17. Forbes S., Bui S., Robinson B.R., Hochgeschwender U., and Brennan M.B. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A 98 (2001) 4233-4237
18. Hoggard N., Hunter L., Duncan J.S., and Rayner D.V. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system. J Mol Endocrinol 32 (2004) 145-153
19. Reinehr T., Hebebrand J., Friedel S., Toschke A.M., Brumm H., Biebermann H., et al. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity (Silver Spring). 17 (2009) 382-389
20. Reinehr T., de Sousa G., Toschke A.M., and Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr. 84 (2006) 490-496
21. Reinehr T., Kersting M., Alexy U., and Andler W. Long-term follow-up of overweight children: after training, after a single consultation session and without treatment. J Pediatr Gastroenterol Nutr 37 (2003) 72-74
22. Farooqi I.S., Keogh J.M., Yeo G.S.H., Lank E.J., Cheetham T., and O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Eng J Med 348 (2003) 1085-1095
23. Nijenhuis W.A., Garner K.M., van Rozen R.J., and Adan R.A. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem 278 (2003) 22939-42295
24. Valli-Jaakola K., Lipsanen-Nyman M., Oksanen L., Hollenberg A.N., Kontula K., Bjørbaek C., et al. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese finish children and adults. J Clin Endocrinol Metab 89 (2004) 940-945
25. Roth C.L., Ludwig M., Woelfle J., Fan Z.C., Brumm H., Biebermann H., et al. A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity. Endocrine (2009)
26. Cole T.J. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44 (1990) 45-60
27. Kromeyer-Hauschild K., Wabitsch M., Geller F., Ziegler A., Geiss H.C., Hesse V., et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 149 (2001) 807-818
28. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
29. Hoggard N., Johnstone A.M., Faber P., Gibney E.R., Elia M., Lobley G., et al. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) 61 (2004) 31-39
30. Katsuki A., Sumida Y., Murashima S., Furuta M., Araki-Sasaki R., Tsuchihashi K., et al. Elevated plasma levels of alpha-melanocyte stimulating hormone (alpha-MSH) are correlated with insulin resistance in obese men. Int J Obes Relat Metab Disord 24 (2000) 1260-1264
31. Gavrila A., Chan J.L., Miller L.C., Heist K., Yiannakouris N., and Mantzoros C.S. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration. J Clin Endocrinol Metab 90 (2005) 1047-1054
32. Reinehr T., Kersting M., Wollenhaupt A., Alexy U., Kling B., Ströbele K., et al. Evaluation of the intervention program "OBELDICKS" for obese children and adolescents. Klin Päd 217 (2005) 1-8
33. Hoggard N., Rayner D.V., Johnston S.L., and Speakman J.R. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice. J Mol Endocrinol 33 (2004) 693-703
34. Fujii N., Jessen N., and Goodyear L.J. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 291 (2006) E867-877
35. Roth C., Wilken B., Hanefeld F., Schröter W., and Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138 (1998) 89
36. Roth C.L., Enriori P.J., Hinney A., Hebebrand J., Reinehr T., and Cowley M.A. Peripheral α-MSH in childhood obesity and craniopharyngioma. The Endocrine Society's 89th Abstract, Annual Meeting, San Francisco (2008)